SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David S. who wrote (3662)1/25/1998 4:56:00 PM
From: JOHN W.  Read Replies (1) of 6136
 
Yeah I remember you suggesting AIDS patients try chicken soup.

Your brand of B.S. has the lifespan of a Hong Kong chicken, put that in your soup.

PW (1/23/98) cont:

"Sizeable market opportunity. We estimate that there are approx 400,000 HIV infected patients in Europe representing a sizable market.. We expect the pricing for the product will be similiar to the U.S. AGPH will receive royalties on product sales (we estimate 10-14%) that step-up with increasing sales. Agouron also recognizes manufacturing revenues from supplying Viracept to Roche."

cont....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News